🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Multi-institutional team awarded $3.4M NCI grant to open AML trial. cancerletter.com/in-brief/20250…

CHMP adopts positive opinion of cabozantinib for previously treated advanced neuroendocrine tumors cancerletter.com/drugs-and-targ…

Last month, the forces aligned and Kinder Children’s Cancer Center (Kinder Children’s Cancer Center), a joint venture of MD Anderson Cancer Center and Texas Children's, was ushered into existence. cancerletter.com/clinical/20250…

MD Anderson and Texas Children's have entered into a collaboration to build a $1 billion pediatric cancer hospital. Peter WT Pisters, MD Anderson Cancer Center president, appears as a special guest in this week’s episode of The Cancer Letter Podcast. cancerletter.com/podcastc/20260…

Rucaparib maintenance therapy demonstrates PFS benefit for HRD-negative and HRD-positive ovarian cancer cancerletter.com/clinical-round…

A new study from Moffitt Cancer Center/Health Choice Network explores what patients affected by cancer ask AI chatbots—and minimize the risks of misinformation or misunderstanding. cancerletter.com/trials-and-tri…

.RWJBarnabas Health, @rutgerscancer Institute welcomes first patients cancerletter.com/in-brief/20250…

.Congressman Raul Ruiz, M.D. said Kennedy’s MAHA report was “riddled with mistakes, misconstruing and, intentionally or not, misstating key references, data and evidence that either do not exist or not accurately reflected in the report.” cancerletter.com/capitol-hill/2…

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts—What the scientific method obscures. Guest editorial by UI Holden Comprehensive Cancer Center's George Weiner and Johns Hopkins Kimmel Cancer Center Elizabeth Jaffee cancerletter.com/guest-editoria…

Congress passes Trump’s megabill featuring historically steep Medicaid cuts cancerletter.com/cancer-policy/…

As a surgeon at UT @MDAndersonnews, I often looked out the window at Texas Children's and thought of possibilities for collaborating. After years of hearing that was impossible, I am thrilled for our joint venture to launch Kinder Children’s Cancer Center. bit.ly/4euCHsY

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research cancerletter.com/clinical/20250…

“It was a one-hour conversation over lunch. That was it,” Pisters (MD Anderson Cancer Center) said. “It was a pivotal hour in the history of MD Anderson, Texas Children's, and for children with cancer.” cancerletter.com/clinical/20250…

Duvelisib + romidepsin combination effective for T-cell lymphoma patients, @Mass General Brigham study shows cancerletter.com/clinical-round…

In weekly vigils, current and former NIH staff grieve the impact of Trump cuts The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater cancerletter.com/the-cancer-let…

Publications based on NIH-funded science must be made free immediately, HHS decrees cancerletter.com/cancer-policy/…

Neil Iyengar joins Winship Cancer Institute of Emory University as survivorship director, co-director of Breast Oncology Program cancerletter.com/in-brief/20250…

Scaling excellence: How City of Hope is transforming cancer care delivery Guest editorial by City of Hope's Alan Bryce and Walter Stadler cancerletter.com/sponsored-arti…

FDA grants accelerated approval to Zegfrovy for NSCLC with EGFR exon20ins cancerletter.com/drugs-and-targ…

NCI approved clinical research studies last month in recurrent glioblastoma, lymphoma, metastatic colorectal cancer, neuroblastoma, Ewing sarcoma, gastric carcinomatosis, bladder cancer, pancreatic cancer, and exercise oncology. cancerletter.com/nci-trials/202…